Balaxi Pharmaceuticals Ltd Financials Statements

    Annual and Quarterly P/L, Balance Sheet, Cash Flow & Financial Ratios

    Consolidate
    Standalone
    Financial Year
    Mar '25
    Dec '24
    Sep '24
    Jun '24
    Mar '24
    Total Qtr Revenue cr
    74.57
    77.23
    73.27
    63.77
    58.05
    Other Income Qtr Cr-1.693.94-4.11-1.85-1.79
    Operating Revenues Qtr76.2773.2977.3865.6259.83

    *All values are in Cr.

    Operating Expenses Qtr
    63.71
    69.30
    66.79
    55.54
    46.37
    Operating Profit Qtr
    12.55
    3.99
    10.59
    10.09
    13.47
    EBITDA Qtr Cr
    10.86
    7.93
    6.48
    8.24
    12.77
    Depreciation Qtr
    0.46
    0.48
    0.46
    0.49
    0.67
    Net Profit Qtr
    8.64
    5.36
    4.59
    6.48
    10.93
    Basic EPS Qtr
    1.56
    0.97
    0.84
    1.17
    10.41
    Open Demat Account
    +91 -

    Open Demat Account
    +91 -